uniQure (QURE) Capital Expenditures (2016 - 2026)
uniQure (QURE) posted quarterly Capital Expenditures of $472000.0 for Q2 2026, up 81.54% year-over-year from $260000.0 in Q2 2025, and up 237.14% quarter-over-quarter from $140000.0 in Q1 2026.
Analysis
uniQure (QURE) Capital Expenditures (2016 - 2026) Analysis & Trends
uniQure's Capital Expenditures history runs 11 years deep, the most recent figure standing at $472000.0 for Q2 2026.
- In Q2 2026, Capital Expenditures rose 81.54% year-over-year to $472000.0; the TTM figure through Jun 2026 stood at $665000.0 (down 17.49% YoY), while the FY2025 annual figure was $439000.0, down 86.97% from the prior year.
- Capital Expenditures for Q2 2026 stood at $472000.0, up from $140000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $5.1 million in Q4 2022, with the low at -$66000.0 in Q3 2025.
- The 5-year median for Capital Expenditures is $839000.0 (2023), against an average of $1.6 million.
- Peak annual rise in Capital Expenditures reached 197.5% in 2025, while the deepest fall reached 117.37% in 2025.
- uniQure's Capital Expenditures stood at $5.1 million in 2022, then plunged by 59.77% to $2.0 million in 2023, then sank by 98.04% to $40000.0 in 2024, then surged by 197.5% to $119000.0 in 2025, then jumped by 296.64% to $472000.0 in 2026.
- Business Quant data shows QURE's Capital Expenditures at $472000.0 in Q2 2026, $140000.0 in Q1 2026, and $119000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 37.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 2.29 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 25.02 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 34.68 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 251.02 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 6.26 Mn |
| 10 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn | 472,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 472,000.00 |
| Mar 31, 2026 | 140,000.00 |
| Dec 31, 2025 | 119,000.00 |
| Sep 30, 2025 | -66,000.00 |
| Jun 30, 2025 | 260,000.00 |
| Mar 31, 2025 | 126,000.00 |
| Dec 31, 2024 | 40,000.00 |
| Sep 30, 2024 | 380,000.00 |
| Jun 30, 2024 | 604,000.00 |
| Mar 31, 2024 | 2.34 Mn |
| Dec 31, 2023 | 2.04 Mn |
| Sep 30, 2023 | 1.70 Mn |
| Jun 30, 2023 | 1.07 Mn |
| Mar 31, 2023 | 2.34 Mn |
| Dec 31, 2022 | 5.07 Mn |
| Sep 30, 2022 | 3.99 Mn |
| Jun 30, 2022 | 4.58 Mn |
| Mar 31, 2022 | 4.06 Mn |
| Dec 31, 2021 | 3.55 Mn |
| Sep 30, 2021 | 7.69 Mn |